Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

NCT02045056 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Preclinical Alzheimer's Disease

Interventions

DRUG: Gemfibrozil
DRUG: Placebo

Sponsor

Gregory Jicha, 323-5550